Neuroblastoma is an embryonal malignancy arising from neural crest cells, which are precursors of sympathetic nervous system ganglion cells. It is the most common extracranial solid tumor of childhood, with approximately 35-40% of cases originating from the adrenal medulla. The median age at diagnosis is 18 months, and over 90% of cases are diagnosed before age 5. The tumor contains calcification in 80-90% of cases, which is a critical diagnostic clue. Neuroblastoma characteristically crosses the midline, can encase vascular structures (but usually does not invade them), and is metastatic in 50-60% of cases at diagnosis. Urinary catecholamine metabolites (VMA, HVA) are elevated in 90% of patients. MIBG scintigraphy is the gold standard nuclear medicine modality for both diagnosis and staging. Prognosis depends on age, stage, MYCN amplification, and histopathological classification (Shimada); patients under 18 months without MYCN amplification have a significantly better prognosis.
Age Range
0-10
Peak Age
2
Gender
Equal
Prevalence
Rare
Neuroblastoma develops from arrested or disordered maturation of embryonic neural crest cells into sympathetic ganglion cells. Neural crest cells normally differentiate into adrenal medullary chromaffin cells and paravertebral sympathetic chain ganglion cells; arrest of this process leads to uncontrolled proliferation. Tumor cells retain the ability to synthesize catecholamines — dopamine, norepinephrine, and their metabolites (VMA, HVA) are overproduced; detection of these metabolites in urine provides 90% diagnostic sensitivity. The norepinephrine transporter system (NET) in the catecholamine synthesis pathway enables active uptake of MIBG (meta-iodobenzylguanidine) into tumor cells; MIBG, as a norepinephrine analog, is internalized via NET and when labeled with I-123 or I-131 allows scintigraphic imaging — this mechanism underlies the high sensitivity and specificity of MIBG scintigraphy in neuroblastoma. The tumor's strong tendency toward calcification (80-90%) results from ischemic necrosis and dystrophic calcification due to inadequate vascularization during rapid growth; on CT, these calcifications appear as amorphous, coarse, or fine granular patterns and are detected as hyperdense due to attenuation of X-rays by high atomic number calcium. The tumor's tendency to cross the midline and encase vessels reflects the growth pattern following embryonic neural crest cell migration routes. On MRI, the tumor appears heterogeneously hyperintense on T2 because areas of high cellularity (intermediate signal), necrosis (high signal), and calcification/fibrosis (low signal) coexist.
A pediatric suprarenal mass crossing the midline to the contralateral side and encasing major vessels without invasion is the most characteristic finding of neuroblastoma, critically important for differentiation from Wilms tumor (renal origin, does not cross midline, causes renal vein thrombosis).
Coarse, amorphous, or fine granular calcifications in 80-90% of cases within a large, heterogeneous density mass in the suprarenal region on non-contrast CT. Calcifications are scattered throughout the tumor and intermixed with areas of necrosis. The calcification pattern is typically irregular and clustered, differing from benign calcifications (thin, peripheral). The presence of calcification is an important criterion for differentiating from Wilms tumor (10-15% calcification).
Report Sentence
Large heterogeneous mass with coarse calcifications in the suprarenal region, consistent with childhood neuroblastoma.
Heterogeneous enhancement pattern on contrast-enhanced CT in arterial and portal venous phases. Solid components of the tumor show moderate to marked enhancement, while areas of necrosis and cystic degeneration do not enhance. Characteristically, the mass crosses the midline (aorta and IVC level) extending to the contralateral side. Major vessels (aorta, IVC, celiac trunk, SMA, renal arteries) are encased by the tumor but typically not invaded — this 'encasement without invasion' pattern is a distinguishing feature of neuroblastoma. The tumor may also show epidural extension into the spinal canal (dumbbell tumor).
Report Sentence
Heterogeneously enhancing mass crossing the midline extending bilaterally into the suprarenal and retroperitoneal spaces; the aorta and IVC are encased by tumor without evidence of invasion.
Heterogeneous, predominantly hyperintense mass on T2-weighted images. Areas of high cellularity show intermediate signal intensity, while necrosis and cystic degeneration areas appear markedly hyperintense. Areas of calcification and hemosiderin deposition appear as low-signal (hypointense) foci on T2. This heterogeneous appearance — coexistence of necrosis, calcification, hemorrhage, and solid components — is the characteristic MR feature of neuroblastoma. Epidural extension into the spinal canal is best evaluated on T2 because the contrast between tumor tissue and surrounding CSF is prominent.
Report Sentence
Heterogeneously hyperintense mass in the suprarenal region on T2-weighted sequences with mixed signal areas due to necrosis, calcification, and hemorrhage.
Marked diffusion restriction in solid components of the tumor on diffusion-weighted imaging (DWI) — hyperintense signal at high b-values (b=800-1000) and low signal on ADC maps. ADC values are typically 0.6-1.0 x 10⁻³ mm²/s. Necrotic areas do not show diffusion restriction (high ADC). The degree of diffusion restriction correlates with tumor cellularity and aggressiveness; low ADC values have been associated with poor prognosis (MYCN amplification). DWI is also valuable for early detection of bone marrow metastases.
Report Sentence
Diffusion restriction is observed in solid components of the mass, consistent with high cellularity; this finding should be evaluated in favor of aggressive neuroblastoma.
Intense uptake in the primary tumor on I-123 or I-131 MIBG scintigraphy. MIBG demonstrates 90-95% sensitivity and 95-100% specificity for neuroblastoma diagnosis. Scintigraphy also detects bone, bone marrow, liver, and soft tissue metastases, providing whole-body staging capability. In MIBG-negative cases (<10%), FDG PET-CT can be used as an alternative. Serial MIBG scintigraphy is the gold standard for treatment response assessment. I-131 MIBG is also used therapeutically (radionuclide therapy in high-risk neuroblastoma).
Report Sentence
Intense pathological uptake in the primary adrenal mass on I-123 MIBG scintigraphy, strongly supporting the diagnosis of neuroblastoma.
The mass generally shows hypointense to isointense signal on T1-weighted images. Areas of hemorrhage appear as hyperintense foci on T1 — subacute hemorrhage (methemoglobin) gives bright signal through T1-shortening effect. Heterogeneous enhancement on contrast-enhanced T1; solid components enhance while necrotic areas do not. Extension into the spinal canal (dumbbell lesion) is best evaluated on contrast-enhanced T1.
Report Sentence
Hypointense mass with hyperintense foci due to hemorrhage on T1-weighted images and heterogeneous enhancement on contrast-enhanced series.
Encasement of major vessels is best evaluated in portal venous phase. The aorta, IVC, celiac trunk, SMA, and renal arteries may be encased but the vessel lumen typically remains patent. Neuroblastoma has low tendency to invade vessel walls (renal vein thrombosis rare unlike Wilms tumor). The tumor displaces the kidney inferolaterally without invasion (claw sign negative — does not originate from kidney). Liver metastases (especially stage 4S) are best evaluated in portal venous phase.
Report Sentence
The mass encases the aorta and IVC with patent vessel lumens; the kidney is displaced inferolaterally without invasion.
Criteria
Infant under 12 months, localized primary tumor (stage 1 or 2), metastasis limited to skin, liver, and/or bone marrow (<10% involvement), no bone metastasis
Distinct Features
May show spontaneous regression without treatment; massive hepatomegaly (Pepper syndrome) due to liver metastasis — diffuse liver lesions on CT/MRI; prognosis excellent with 85-90% survival
Criteria
MYCN oncogene amplification (>10 copies), usually >18 months, stage 3-4, unfavorable histopathology (Shimada)
Distinct Features
Aggressive behavior, rapid growth, widespread metastasis tendency; more heterogeneous and necrotic on imaging; marked diffusion restriction on DWI; requires multimodal therapy (chemotherapy + surgery + stem cell transplant + anti-GD2 immunotherapy); 5-year survival 40-50%
Criteria
Epidural extension of paraspinal tumor into spinal canal through neural foramina, hourglass configuration
Distinct Features
May present with spinal cord compression and neurological deficits (emergency); neural foraminal widening pathognomonic on CT; MRI assessment of epidural component and cord compression mandatory; surgical planning for both components required
Criteria
Predominantly cystic tumor, usually diagnosed prenatally or neonatally, frequently low stage
Distinct Features
Cystic adrenal mass on US — must be differentiated from adrenal hemorrhage and simple cyst; thin wall enhancement or solid nodule suggests malignancy; prognosis generally very good; follow-up or minimal surgery may suffice
Distinguishing Feature
Ganglioneuroblastoma is a more mature form; less calcification, more homogeneous enhancement, better defined mass on CT; necrosis and hemorrhage less prominent; contains Schwannian stroma and ganglion cells histologically
Distinguishing Feature
Ganglioneuroma is a completely benign mature tumor; homogeneous T2 hyperintense signal on MRI (myxoid stroma), late progressive enhancement, calcification rare; usually in older children and adolescents; MIBG uptake negative or mild
Distinguishing Feature
Pheochromocytoma also shows MIBG uptake but typically in adults; 'light bulb sign' on T2; catecholamine levels very high (hypertensive crises); calcification rare; rare in children, frequently hereditary syndrome-associated (MEN2, VHL, NF1)
Distinguishing Feature
Wilms tumor originates from the kidney (claw sign positive), usually does not cross midline, calcification only 10-15%, renal vein/IVC thrombus common (4-10%), vessel encasement not typical; neuroblastoma is adrenal origin, crosses midline, 80-90% calcification, vessel encasement but thrombosis rare
Distinguishing Feature
Adrenocortical carcinoma very rare in children; usually hormonally active (virilization, Cushing); calcification 30%; midline crossing and vessel encasement not as prominent; MIBG negative; urinary catecholamines normal; serum androgen/cortisol elevated
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralNeuroblastoma is a pediatric oncologic emergency requiring rapid multidisciplinary evaluation. Risk stratification (age, stage, MYCN amplification, histopathology, DNA ploidy) determines the treatment plan. Low-risk patients may be treated with observation or minimal surgery, while high-risk patients require aggressive multimodal therapy including induction chemotherapy, surgical resection, high-dose chemotherapy + autologous stem cell transplant, radiation therapy, I-131 MIBG therapy, and anti-GD2 immunotherapy. Spinal cord compression requires emergent intervention. Stage 4S may only require observation due to spontaneous regression potential.
Neuroblastoma treatment approach varies by stage. MIBG scintigraphy is the gold standard for staging and follow-up. MYCN amplification is a poor prognostic factor. Stage 4S may show spontaneous regression.